Displaying results 1 - 3 of 3
EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022 • Description The WHO goal of eliminating viral hepatitis by 2030 has led to a surge in activities to achieve a world free from viral liver disease. What steps must be taken? How do you define sustainable elimination? Listen to the experts debriefing the Viral Hepatitis Elimination Conference 2022. Discover the highlights of the conference and learn more about what successful countries have done to achieve viral hepatitis elimination.
EASL Studio: Midday Talks: HBV and HDV drug development - Where do we stand and where are we going? - 23 June 2022 • HBV/HDV Roundtable: HBV and HDV drug development - Where do we stand and where are we going? Prof. Pietro Lampertico (Moderator), Prof. Sabela Lens (Moderator), Dr John Flaherty (Faculty), Dr Melanie Paff (Faculty), Dr Gastón R. Picchio (Faculty), Prof. Mala Maini (Faculty) This EASL Studio is supported by Arbutus Biopharma, Gilead Sciences, and GSK. ℹ️ Please click here to access the podcast version of this EASL Studio episode.
EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe • Description In this first episode, the experts are discussing the multifaceted issue of drug use in relation to the hepatitis C elimination in Europe. How far are we from hepatitis C elimination in Europe? How are drug use and hepatitis C issues related? How can the work of the European Parliament contribute to eliminating hepatitis?